[HTML] nature.com

[HTML][HTML] In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

F Touret, M Gilles, K Barral, A Nougairède… - Scientific reports, 2020 - nature.com
A novel coronavirus, named SARS-CoV-2, emerged in 2019 in China and rapidly spread
worldwide. As no approved therapeutics exists to treat COVID-19, the disease associated to …
被引用次数：412 相关文章
[HTML] nih.gov

[HTML][HTML] In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

F Touret, M Gilles, K Barral, A Nougairède… - Scientific …, 2020 - ncbi.nlm.nih.gov
A novel coronavirus, named SARS-CoV-2, emerged in 2019 in China and rapidly spread
worldwide. As no approved therapeutics exists to treat COVID-19, the disease associated to …

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

F Touret, M Gilles, K Barral, A Nougairède… - Scientific …, 2020 - ird.hal.science
A novel coronavirus, named SARS-CoV-2, emerged in 2019 in China and rapidly spread
worldwide. As no approved therapeutics exists to treat COVID-19, the disease associated to …

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

F Touret, M Gilles, K Barral, A Nougairède… - 2020 - agris.fao.org
A novel coronavirus, named SARS-CoV-2, emerged in 2019 in China and rapidly spread
worldwide. As no approved therapeutics exists to treat COVID-19, the disease associated to …

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

F Touret, M Gilles, K Barral, A Nougairède… - Scientific …, 2020 - inserm.hal.science
A novel coronavirus, named SARS-CoV-2, emerged in 2019 in China and rapidly spread
worldwide. As no approved therapeutics exists to treat COVID-19, the disease associated to …

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

F Touret, M Gilles, K Barral, A Nougairede… - 2020 - documentation.ird.fr
A novel coronavirus, named SARS‑CoV‑2, emerged in 2019 in China and rapidly spread
worldwide. As no approved therapeutics exists to treat COVID‑19, the disease associated to …

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication.

F Touret, M Gilles, K Barral, A Nougairède… - 2020 - cabidigitallibrary.org
A novel coronavirus, named SARS-CoV-2, emerged in 2019 in China and rapidly spread
worldwide. As no approved therapeutics exists to treat COVID-19, the disease associated to …
[PDF] researchgate.net

[PDF][PDF] In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication 2

F Touret, M Gilles, K Barral, A Nougairède, E Decroly… - researchgate.net
A novel coronavirus, named SARS-CoV-2, emerged in 2019 from Hubei region in China and
rapidly 19 spread worldwide. As no approved therapeutics exists to treat Covid-19, the …

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

F Touret, M Gilles, K Barral, A Nougairède… - Scientific …, 2020 - ui.adsabs.harvard.edu
A novel coronavirus, named SARS-CoV-2, emerged in 2019 in China and rapidly spread
worldwide. As no approved therapeutics exists to treat COVID-19, the disease associated to …

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

F Touret, M Gilles, K Barral, A Nougairède… - Scientific Reports, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> A novel coronavirus, named SARS-CoV-2,
emerged in 2019 in China and rapidly spread worldwide. As no approved therapeutics …